Quotient Limited to Participate in the Jefferies Virtual Healthcare Conference
Quotient Limited (NASDAQ: QTNT) announced its presentation at the Jefferies Virtual Healthcare Conference on June 2, 2020, at 9:00 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Quotient Limited (NASDAQ: QTNT) announced its presentation at the Jefferies Virtual Healthcare Conference on June 2, 2020, at 9:00 a.m. ET. A webcast of the presentation will be available on the investor relations page of the Company's website and archived for approximately 90 days.
Quotient, a commercial-stage diagnostics company with 30 years of experience in transfusion diagnostics, is known for its MosaiQ technology. This innovative platform offers fully automated testing, enhancing efficiency and cost-effectiveness in laboratories worldwide.
Details
News Market Reaction – QTNT
The recorded move for QTNT in the trading session of this news was -4.68%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
JERSEY, Channel Islands, May 26, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the Company will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 9:00 a.m. ET.
A webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.quotientbd.com. A webcast replay will be archived on the website for approximately 90 days.
About Quotient Limited
Building on 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. The MosaiQ platform is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and operational cost savings to laboratories around the world. Quotient's operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania. The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.
Contacts:
Peter Buhler, Chief Financial Officer, peter.buhler@quotientbd.com; +41 22 545 52 26
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.